grant

Dynamics and evolution of synthetic and natural gene regulatory networks

Organization STATE UNIVERSITY NEW YORK STONY BROOKLocation STONY BROOK, UNITED STATESPosted 1 Apr 2017Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY2025AddressAnti-microbial Drug ResistanceAnti-microbial Drug ResistantAntimicrobial Drug ResistanceAntimicrobial Drug ResistantArtificial GenesBehaviorBindingBiologicalCancerousCell BodyCellsCodeCoding SystemComplexComputer ModelsComputerized ModelsDNADNA SequenceDNA mutationDeoxyribonucleic AcidDiseaseDisorderDisparateDrug resistanceEducational process of instructingEnvironmentEvolutionFunctional RNAGenesGenetic ChangeGenetic defectGenetic mutationHumanIndividualMammalian CellMicrobial Drug ResistanceModern ManMolecular InteractionMutationNoncoding RNANontranslated RNANucleic Acid Regulator RegionsNucleic Acid Regulatory SequencesPatternPhenotypePopulationProteinsRegulatory RegionsResearchSynthetic GenesTeachingTimeUntranslated RNAYeastsbehavior influencebehavioral influencebiologiccancer drug resistancecancer progressioncell behaviorcellular behaviorcomputational modelingcomputational modelscomputer based modelscomputerized modelingdesigndesigningdrug resistantdrug-sensitivegene networkgene productgene regulatory networkgenetic evolutiongenetic regulatory elementgenome mutationhuman tissuemicrobialmicrobial drug resistantneoplasm progressionneoplastic progressionnon-geneticnoncodingnongeneticpreventpreventingprotein expressionresistance to Drugresistance to cancer drugsresistant to Drugresistant to cancer drugssingle cell analysistumor progression
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary: MIRA R35 GM122561 renewal
Title: Dynamics and evolution of synthetic and natural gene regulatory networks

Human tissues or microbial cell populations can consist of millions of cells, each of which contains

billions of molecules. Central among these molecules, DNA stores information in protein-coding

genes, but also in noncoding, gene-regulatory regions. Gene products binding to such regions or to

each other form complex gene regulatory networks that influence the behavior of individual cells and

thereby cell populations. DNA sequence mutations can alter these networks as cell populations adapt

to various environments, contributing to genetic evolution. Yet, to thoroughly understand adapting and

evolving cell populations, we must also ask how cells and thereby cell populations respond to gene

network dynamics and stochasticity, apart from or combined with DNA mutations. Answering these

questions should deepen the understanding of the behavior and evolution of cell populations, which

underlie cancer progression and microbial drug resistance.

Before 2017, we developed computational models of natural gene regulatory networks to understand

how they modulate nongenetic diversity in cell populations and designed synthetic gene circuits to

control the variability of protein expression in yeast and mammalian cells. Since 2017, with MIRA

support we started bringing these research directions closer, by seeking control points in natural gene

networks and devising synthetic gene circuits to control expression patterns of native genes in space

and time. We will now combine and study natural and synthetic gene networks by precisely perturbing

the expression of specific native genes, to examine subsequent effects on the native gene network,

single-cell and cell population phenotypes, as well as evolution by computational modeling, single-cell

analysis and experimental evolution. Overall, these studies will reveal how complex networks enable

biological control across disparate scales of space and time, from molecules to cells, from seconds to

weeks. Addressing these questions will teach us how to control evolving cell populations, which is

relevant for understanding, predicting and possibly preventing cancer and microbial drug resistance.

Grant Number: 5R35GM122561-10
NIH Institute/Center: NIH

Principal Investigator: Gabor Balazsi

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →